BRPI0618482A2 - nucleobase contendo grupo perfluoroaquila e processo para a produção da mesma - Google Patents

nucleobase contendo grupo perfluoroaquila e processo para a produção da mesma Download PDF

Info

Publication number
BRPI0618482A2
BRPI0618482A2 BRPI0618482-0A BRPI0618482A BRPI0618482A2 BR PI0618482 A2 BRPI0618482 A2 BR PI0618482A2 BR PI0618482 A BRPI0618482 A BR PI0618482A BR PI0618482 A2 BRPI0618482 A2 BR PI0618482A2
Authority
BR
Brazil
Prior art keywords
nucleobase
production
perfluoroalkyl group
nucleobase containing
containing perfluoroalkyl
Prior art date
Application number
BRPI0618482-0A
Other languages
English (en)
Inventor
Tetsu Yamakawa
Kyoto Yamamoto
Daisuke Uraguchi
Kenji Tokuhisa
Original Assignee
Tosoh Corp
Tosoh F Tech Inc
Sagami Chem Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosoh Corp, Tosoh F Tech Inc, Sagami Chem Res filed Critical Tosoh Corp
Publication of BRPI0618482A2 publication Critical patent/BRPI0618482A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

NUCLEOBASE CONTENDO GRUPO PERFLUOROAQUILA E PROCESSO PARA A PRODUçãO DA MESMA. A presente invenção refere-se a um processo de produção simples e eficiente de uma nucleobase contendo um grupo perrluoroalquila. Uma nucleobase (por exemplo, uracilas, citosinas, adeninas,guaninas, hipoxantinas, xantinas, ou similares) é reagida com um haleto de perfluoroalquila na presença de um sulfóxido, um peróxido e um composto de ferro para produzir uma nucleobase substituida por períluoroalquila, que é útil como um intermediário para fármacos medicinais, economicamente.
BRPI0618482-0A 2005-11-09 2006-11-06 nucleobase contendo grupo perfluoroaquila e processo para a produção da mesma BRPI0618482A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005324943 2005-11-09
PCT/JP2006/322094 WO2007055170A1 (ja) 2005-11-09 2006-11-06 パーフルオロアルキル基を有する核酸塩基類およびその製造方法

Publications (1)

Publication Number Publication Date
BRPI0618482A2 true BRPI0618482A2 (pt) 2011-08-30

Family

ID=38023173

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0618482-0A BRPI0618482A2 (pt) 2005-11-09 2006-11-06 nucleobase contendo grupo perfluoroaquila e processo para a produção da mesma

Country Status (9)

Country Link
US (1) US7884202B2 (pt)
EP (1) EP1947092B1 (pt)
KR (1) KR101388688B1 (pt)
CN (1) CN101304977B (pt)
AU (1) AU2006313123B2 (pt)
BR (1) BRPI0618482A2 (pt)
CA (1) CA2631129A1 (pt)
RU (1) RU2436777C2 (pt)
WO (1) WO2007055170A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2644333C (en) * 2006-11-06 2014-05-06 Sagami Chemical Research Center Reaction reagent for trifluoromethylation
SG10201913554YA (en) 2011-12-22 2020-03-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US20140135497A1 (en) * 2012-11-13 2014-05-15 Boehringer Ingelheim International Gmbh Synthesis of 2,4-dichloro-5-trifluoromethyl-pyrimidine
WO2014126954A1 (en) 2013-02-13 2014-08-21 OSI Pharmaceuticals, LLC Regioselective synthesis of substituted pyrimidines
CN103788095A (zh) * 2014-01-20 2014-05-14 四川大学华西医院 2,4(1h,3h)-嘧啶二酮衍生物及其制备方法
HUE036625T2 (hu) 2014-06-06 2018-07-30 Lonza Ag Eljárás fluor-, klór- és fluor-klór-alkilezett vegyületek elõállítására heterogén katalízis révén
CN105175467B (zh) * 2014-06-11 2020-07-17 江苏豪森药业集团有限公司 曲氟尿苷的新晶型及其制备方法
CN105198946A (zh) * 2014-06-11 2015-12-30 江苏豪森药业股份有限公司 新的曲氟尿苷晶型及其制备方法
CN104744466A (zh) * 2014-10-31 2015-07-01 合肥平光制药有限公司 一种高纯度茶碱的合成方法
WO2019020726A1 (en) 2017-07-28 2019-01-31 Lonza Ltd PROCESS FOR THE PREPARATION OF ALKYL OR FLUORO, CHLORO AND FLUOROCHLORO ALKYL COMPOUNDS BY COBALT HETEROGENEOUS CATALYSIS
CA3070021A1 (en) * 2017-07-28 2019-01-31 Lonza Ltd Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis
CN107652341B (zh) * 2017-11-10 2019-10-11 上海兆维科技发展有限公司 一种制备“曲氟尿苷”的改进方法
CA3107170A1 (en) 2018-08-06 2020-03-12 Skylark Bioscience Llc Amp-activated protein kinase activating compounds and uses thereof
US11827667B2 (en) 2018-09-14 2023-11-28 University Of Miyazaki Production method for guanosine derivative having fluorine atom-containing functional group at position 8 and application thereof
EP3917914A1 (en) 2019-02-01 2021-12-08 Fmc Corporation Diamino-substituted pyridines and pyrimidines as herbicides
CN109761914B (zh) * 2019-02-22 2021-03-05 北京瑞博奥生物科技有限公司 一种制备5-三氟甲基尿嘧啶的方法
WO2021183980A1 (en) 2020-03-13 2021-09-16 Fmc Corporation Substituted pyrimidines and triazines as herbicides
US11779590B2 (en) 2020-10-30 2023-10-10 Skylark Bioscience Llc AMP-activated protein kinase activating compounds and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
JPS5566583A (en) * 1978-11-11 1980-05-20 Fisons Ltd Theophylline derivative*its manufacture and pharmacological composition containing it
EP0011399A1 (en) * 1978-11-11 1980-05-28 FISONS plc N-substituted theophyllines, processes for their preparation and pharmaceutical compositions containing them
JPS58152857A (ja) * 1982-03-08 1983-09-10 Daikin Ind Ltd フルオロアシル尿素類又はフルオロアシルチオ尿素類
JPS61257977A (ja) * 1986-05-09 1986-11-15 Daikin Ind Ltd 含フツ素複素環化合物
JPH04503814A (ja) * 1989-06-21 1992-07-09 ザ・キャソリック・ユニバーシティー・オブ・アメリカ 抗マラリア組成物及び使用方法
NZ238609A (en) * 1990-06-21 1993-12-23 Schering Corp Polycyclic guanine derivatives; preparation, pharmaceutical compositions,
JPH04149193A (ja) * 1990-10-15 1992-05-22 Nippon Oil & Fats Co Ltd ポリフルオロアルキル基含有ウリジン誘導体及びその製造方法
JP3032837B2 (ja) * 1991-02-14 2000-04-17 工業技術院長 フルオロアルキル基含有ピリミジン誘導体及びその製造方法
JP3086912B2 (ja) 1991-06-20 2000-09-11 工業技術院長 フルオロアルキル基含有プリン誘導体及びその製造方法
DE4222518A1 (de) 1992-07-09 1994-01-13 Bayer Ag Verfahren zur Hertellung von 5-(Trifluormethyl)-uracil und die neuen Verbindungen 2,4-Dichlor-5-trichlormethyl-pyrimidin und 2,4-Difluor-5-trifluormethyl-pyrimidin
JPH11246590A (ja) 1998-02-25 1999-09-14 Asahi Glass Co Ltd トリフルオロメチルウラシル誘導体の製造方法
JP2001247551A (ja) 2000-03-09 2001-09-11 Mitsui Chemicals Inc ５−パーフルオロアルキルウラシル誘導体の製造法
JP4503814B2 (ja) 2000-11-28 2010-07-14 Ｊｕｋｉ株式会社 電子部品搭載装置
JP4149193B2 (ja) 2002-05-15 2008-09-10 富士通株式会社 多軸ねじ締め機におけるねじ供給方法及びねじ供給トレイ
JP4261161B2 (ja) 2002-11-14 2009-04-30 株式会社岡村製作所 ソファー兼用ベッド
GB0328024D0 (en) 2003-12-03 2004-01-07 Glaxo Group Ltd Compounds
JP2005324943A (ja) 2004-05-17 2005-11-24 Iwatsu Electric Co Ltd 画像形成装置
KR20070070231A (ko) * 2004-10-22 2007-07-03 스미스클라인 비참 코포레이션 Ｈｍ７４ａ 수용체 활성을 가지는 크산틴 유도체
CA2644333C (en) 2006-11-06 2014-05-06 Sagami Chemical Research Center Reaction reagent for trifluoromethylation

Also Published As

Publication number Publication date
US7884202B2 (en) 2011-02-08
CN101304977B (zh) 2014-08-13
AU2006313123A1 (en) 2007-05-18
US20090124796A1 (en) 2009-05-14
EP1947092B1 (en) 2015-04-15
WO2007055170A1 (ja) 2007-05-18
EP1947092A1 (en) 2008-07-23
KR20080066021A (ko) 2008-07-15
CN101304977A (zh) 2008-11-12
CA2631129A1 (en) 2007-05-18
AU2006313123B2 (en) 2012-01-12
RU2436777C2 (ru) 2011-12-20
KR101388688B1 (ko) 2014-04-24
RU2008122948A (ru) 2009-12-20
EP1947092A4 (en) 2009-12-09

Similar Documents

Publication Publication Date Title
BRPI0618482A2 (pt) nucleobase contendo grupo perfluoroaquila e processo para a produção da mesma
TNSN08444A1 (en) Bicyclic derivatives as cetp inhibitors
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
CY1109696T1 (el) Υποκατεστημενα παραγωγα πυριδινυλιου και πυριμιδινυλιου ως διαμορφωτες του μεταβολισμου και η θεραπεια των σχετικων με αυτον διαταραχων
BRPI0609121B8 (pt) 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2
CY1118061T1 (el) Δικυκλικα παραγωγα heterocyclyl σαν καταστολεις κινασης (kinase) fgfr για θεραπευτικη χρηση
BRPI0813284A8 (pt) Processo para a preparação de um composto da fórmula (i) e composto
BRPI0518758A2 (pt) compostos de acetamida como fungicidas
BR112012010186A2 (pt) derivados de heteroarila contendo n como inibidores de quinase jak3.
ECSP11010885A (es) Heteroarilos sustituidos
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
BRPI0514017A (pt) indazóis úteis no tratamento de doenças cardiovasculares
GT200600327A (es) Ciclohexilaminoisoquinolona
UY29641A1 (es) Derivados de isoquinolina
MA29539B1 (fr) Procedes de production de derives phenoliques 4-biphenylylazetidin -2-one
GT200600328A (es) Derivados de isoquinolona sustituidos con piperidinilo
BRPI0816911A8 (pt) Processo para preparação de 4-aminobut-2-enolidas
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
MX385354B (es) Sales de xantilio 3,6-disustituidas.
BRPI0519496A2 (pt) processo para preparar um composto ou uma composiÇço, e, composiÇço
ECSP10010058A (es) Derivados de quinazolinadiona, su preparación y sus aplicaciones terapéuticas
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
CY1116742T1 (el) Ενωσεις που σχετιζονται με τον tdf και αναλογα τους
GT200600013A (es) Compuestos organicos
JO2581B1 (en) Substituted Arylsulfonamides

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.